documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
22 rows where docket_id = "FDA-2016-N-1149" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 2
- Other 20
- Proposed Rule 2
agency_id 1
- FDA 22
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-1149-0108 | FDA | None FDA-2016-N-1149 | FDA Summary of Premarket Review and Related Authorities for Medical Products _Jan 2025 | Other | Summary (SUM) | 2025-01-06T05:00:00Z | 2025 | 1 | 2025-01-06T05:00:00Z | 2025-01-06T13:37:41Z | 0 | 0 | 090000648689e39a | ||
| FDA-2016-N-1149-0107 | FDA | None FDA-2016-N-1149 | Addendum to Jan 2017 FDA Memo--Additional and Updated Considerations Related to Manufacturer Communications Re Unapproved Uses of Approved or Cleared Medical Products_Jan 2025 | Other | Additional Information | 2025-01-06T05:00:00Z | 2025 | 1 | 2025-01-06T05:00:00Z | 2025-01-06T13:37:28Z | 0 | 0 | 090000648689e398 | ||
| FDA-2016-N-1149-0106 | FDA | None FDA-2016-N-1149 | Letter from Ropes & Gray on behalf of Medical Information Working Group (MIWG) to FDA | Other | Letter(s) | 2019-12-03T05:00:00Z | 2019 | 12 | 2019-12-03T05:00:00Z | 2019-12-03T14:16:13Z | 0 | 0 | 09000064841dde4b | ||
| FDA-2016-N-1149-0105 | FDA | None FDA-2016-N-1149 | Kalb et al_IU Final Rule_Response_3-26-18 | Other | Agency Response | 2018-04-09T04:00:00Z | 2018 | 4 | 2018-04-09T04:00:00Z | 2018-04-09T21:13:27Z | 0 | 0 | 09000064830e95e5 | ||
| FDA-2016-N-1149-0104 | FDA | None FDA-2016-N-1149 | Petition Interim Response from FDA OP to MIWG | Other | Letter(s) | 2017-08-01T04:00:00Z | 2017 | 8 | 2017-08-01T04:00:00Z | 2017-08-01T14:42:16Z | 0 | 0 | 0900006482990a65 | ||
| FDA-2016-N-1149-0087 | FDA | None FDA-2016-N-1149 | Testimony from Anthem Inc. | Other | Testimony | 2017-04-20T04:00:00Z | 2017 | 4 | 2017-04-20T04:00:00Z | 2017-04-20T18:59:26Z | 0 | 0 | 0900006482560beb | ||
| FDA-2016-N-1149-0093 | FDA | None FDA-2016-N-1149 | Testimony from Pfizer Inc. | Other | Testimony | 2017-04-20T04:00:00Z | 2017 | 4 | 2017-04-20T04:00:00Z | 2017-04-20T19:06:43Z | 0 | 0 | 0900006482561a8d | ||
| FDA-2016-N-1149-0075 | FDA | None FDA-2016-N-1149 | Testimony from PharmedOut | Other | Testimony | 2017-04-20T04:00:00Z | 2017 | 4 | 2017-04-20T04:00:00Z | 2017-04-20T16:36:19Z | 0 | 0 | 090000648255df72 | ||
| FDA-2016-N-1149-0048 | FDA | None FDA-2016-N-1149 | Petition to Stay and for Reconsideration | Other | Petition(s) | 2017-02-09T05:00:00Z | 2017 | 2 | 2017-02-09T05:00:00Z | 2017-02-09T15:17:05Z | 0 | 0 | 09000064824b6785 | ||
| FDA-2016-N-1149-0049 | FDA | None FDA-2016-N-1149 | Acknowledgement Letter From FDA DDM to Sidley Austin LLP and Ropes & Gray LLP | Other | Acknowledgement Letter/Receipt | 2017-02-09T05:00:00Z | 2017 | 2 | 2017-02-09T05:00:00Z | 2017-02-09T16:47:18Z | 0 | 0 | 09000064824b6e17 | ||
| FDA-2016-N-1149-0041 | FDA | None FDA-2016-N-1149 | Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products; Availability of Memorandum; Reopening of the Comment Period | Proposed Rule | Reopening of Comment Period | 2017-01-19T05:00:00Z | 2017 | 1 | 2017-01-19T05:00:00Z | 2017-04-20T03:59:59Z | 2017-06-23T01:03:12Z | 2017-01013 | 0 | 0 | 090000648248561c |
| FDA-2016-N-1149-0040 | FDA | None FDA-2016-N-1149 | FDA Memorandum--Public Health Interests and First Amendment Considerations Related to Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products_Jan 2017 | Other | Letter(s) | 2017-01-18T05:00:00Z | 2017 | 1 | 2017-01-18T05:00:00Z | 2017-01-18T15:22:04Z | 0 | 0 | 0900006482480cf8 | ||
| FDA-2016-N-1149-0018 | FDA | None FDA-2016-N-1149 | Testimony from American Association of Neurological Surgeons and Congress of Neurological Surgeons | Other | Testimony | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2016-12-14T21:10:43Z | 0 | 0 | 09000064823ba7a1 | ||
| FDA-2016-N-1149-0013 | FDA | None FDA-2016-N-1149 | Testimony from Advanced Medical Technology Association (AdvaMed) | Other | Testimony | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2016-12-14T20:15:59Z | 0 | 0 | 0900006482381f85 | ||
| FDA-2016-N-1149-0012 | FDA | None FDA-2016-N-1149 | Testimony from Biotechnology Innovation Organization (BIO) | Other | Testimony | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2016-12-14T20:14:51Z | 0 | 0 | 090000648238157d | ||
| FDA-2016-N-1149-0022 | FDA | None FDA-2016-N-1149 | Testimony from Jerome Lew | Other | Testimony | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2016-12-14T21:30:38Z | 0 | 0 | 09000064823f9294 | ||
| FDA-2016-N-1149-0014 | FDA | None FDA-2016-N-1149 | Testimony from National Women's Health Network | Other | Testimony | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2016-12-14T20:23:47Z | 0 | 0 | 0900006482397fc5 | ||
| FDA-2016-N-1149-0011 | FDA | None FDA-2016-N-1149 | Testimony from Floyd Abrams | Other | Testimony | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2016-12-14T19:38:38Z | 0 | 0 | 0900006482364d05 | ||
| FDA-2016-N-1149-0008 | FDA | None FDA-2016-N-1149 | Transcript of Day 1 on November 9, 2016 | Other | Transcript(s) | 2016-12-13T05:00:00Z | 2016 | 12 | 2016-12-13T05:00:00Z | 2016-12-13T17:12:36Z | 0 | 0 | 09000064824016af | ||
| FDA-2016-N-1149-0009 | FDA | None FDA-2016-N-1149 | Transcript of Day 2 on November 10, 2016 | Other | Transcript(s) | 2016-12-13T05:00:00Z | 2016 | 12 | 2016-12-13T05:00:00Z | 2016-12-13T17:13:48Z | 0 | 0 | 09000064824016b0 | ||
| FDA-2016-N-1149-0006 | FDA | None FDA-2016-N-1149 | Testimony from MMpiHer Consulting | Other | Testimony | 2016-10-26T04:00:00Z | 2016 | 10 | 2016-10-26T04:00:00Z | 2016-10-26T16:02:52Z | 0 | 0 | 090000648234f639 | ||
| FDA-2016-N-1149-0001 | FDA | None FDA-2016-N-1149 | Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products; Public Hearing; Request for Comments | Proposed Rule | Notice of Hearing | 2016-09-01T04:00:00Z | 2016 | 9 | 2016-09-01T04:00:00Z | 2017-04-20T03:59:59Z | 2017-04-21T01:02:02Z | 2016-21062 | 0 | 0 | 09000064821bd14a |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;